Plicamycin
Top View
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010
- Molecular and Cellular Mechanisms of Human Astrocytoma Progression: Advances in Knowledge to Reach Therapeutic Horizons
- Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
- 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
- Disease Site-Delivering Pharmaceutical Compositions Comprising Paclitaxel
- Large-Scale Drug Screening in Patient-Derived IDH Glioma Stem
- 2019 Table of Drugs
- OF Publication Classification DISEASES INVOLVING CELL (51) Int
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- MANUAL for Medical Facilities
- Bacille Calmette-Guérin (BCG)
- Chemical Protocol Review
- Supplementary Information for Drug Metabolism and Disposition
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- Patient Drug Locker Procedures
- INJECTABLE CHEMOTHERAPY DRUGS: APPLICATION of NCCN CLINICAL PRACTICE GUIDELINES Policy Number: CANCER 009.18 T2 Effective Date: June 1, 2018
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug Administration Approval